Lesser Known Facts of Small Cell Lung Cancer

Xin Li1, Michael Enzerra, Daniel Arnold Smith

  • 1From the University Hospitals-Cleveland Medical Center, Cleveland, OH.

Insights

Small cell lung cancer (SCLC) treatment is evolving with precision medicine and immunotherapy. Radiologists need updated knowledge of SCLC management and imaging patterns, including treatment complications.

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Small cell lung cancer (SCLC) historically shows initial treatment response but high recurrence rates.
  • SCLC treatment advancements have lagged compared to non-small cell lung cancers.
  • Precision medicine and immunotherapy are changing cancer care paradigms.

Purpose of the Study:

  • To inform radiologists about contemporary SCLC treatment strategies.
  • To familiarize radiologists with imaging findings of modern SCLC therapies.
  • To highlight classic and nonclassic imaging presentations of treatment complications in SCLC.

Main Methods:

  • Review of current literature on SCLC treatment advancements.
  • Analysis of imaging patterns associated with novel SCLC therapies.
  • Correlation of imaging findings with treatment response and complications.

Main Results:

  • SCLC management is shifting towards targeted therapies and immunotherapy.
  • New imaging patterns emerge with advanced SCLC treatments.
  • Recognition of treatment complications on medical imaging is crucial for patient management.

Conclusions:

  • Radiologists require updated knowledge of SCLC treatment paradigms.
  • Familiarity with evolving imaging patterns in SCLC is essential for accurate interpretation.
  • Understanding treatment complications improves patient care in SCLC management.

Related Concept Videos

Lung Capacity01:47

Lung Capacity

The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.2K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
7.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K